• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Biota Pharmaceuticals Inc

+ Add to Watchlist

NB1:GR

1.801 EUR 0.0000.00%

As of 02:16:03 ET on 08/28/2014.

Company Profile for Biota Pharmaceuticals Inc (NB1)

Biota Pharmaceuticals Inc is an anti-infective drug development company with expertise in respiratory diseases, particularly influenza. The Company developed the first neuraminidase inhibitor. Biota's research breakthroughs include a series of candidate drugs aimed at treatment of respiratory syncytial virus (RSV) disease and Hepatitis C (HCV) virus infections.

Contact Information

Biota Pharmaceuticals Inc

12270 Wilkins Avenue
Rockville, MD 20852
United States
Phone: 1-301-770-3099
Fax: 1-301-770-3097

Key Executives for Biota Pharmaceuticals Inc (NB1)

Russell H PlumbPresident/CEOPeter AzzarelloChief Accounting Officer
Joseph M PattiExec VP:Development & Strategy

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil